Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol tartrate nasal spray for uterine contraction pain and prolactin after cesarean section
ChiCTR2200063746Phase 4Not yet recruiting
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in dysmenorrhea comparing Butorphanol tartrate nasal spray with Normal saline nasal spray (placebo) (2 arms). Primary endpoints: Uterine contraction pain and Prolactin level. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
butorphanol
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on ChiCTR2200063746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063746.